RxDoctor Payments Data

Joy Maines, PA

Physician Assistant · Globe, AZNPI 1790958866

Payments from drug & device makers

$1,457in general payments, 2019–2025

Across 81 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$266
  • Novo Nordisk$246
  • AbbVie$237
  • Lilly USA, LLC$115
  • Mimedx Group, Inc.$78
  • Lucid Diagnostics Inc.$77
  • plus $438 from 16 others

What the payments were for

  • Food & beverage$1,43999%
  • Entertainment$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,457 in reported general payments places this provider in the 75th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$46,238
Medicare patients
112
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin130$114,089
OzempicSemaglutide42$39,738
EliquisApixaban35$34,662
Breo ElliptaFluticasone/Vilanterol49$19,508
Stiolto RespimatTiotropium Br/Olodaterol Hcl31$15,644
RybelsusSemaglutide13$14,992
Spiriva RespimatTiotropium Bromide12$14,910
XareltoRivaroxaban16$13,516
EntrestoSacubitril/Valsartan11$7,645
Atrovent HfaIpratropium Bromide14$7,538
Spiriva HandihalerTiotropium Bromide12$7,349
LexaproEscitalopram Oxalate13$5,188
SymbicortBudesonide/Formoterol Fumarate13$3,034
Gabapentin140$2,675
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat$266$144,644173 claims
Novo NordiskOzempic, Rybelsus$246$54,72955 claims
PfizerEliquis$30$34,66235 claims
AbbVieLexapro$237$5,18813 claims
AstraZenecaSymbicort$13$3,03413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Globe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →